SEC Form 4 · accession 0001144204-16-117725
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Przybyl
Officer — President and CEO · Director
Period of report
Aug 9, 2016
Accepted (ET)
Aug 9, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 9, 2016 | G | 836 | $0.00 | D | 176,083 | D |
Table II — derivative securities
No Table II lines on this filing.